| 000 | 01441 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513153535.0 | ||
| 264 | 0 | _c19981027 | |
| 008 | 199810s 0 0 eng d | ||
| 022 | _a0093-7754 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHausheer, F H | |
| 245 | 0 | 0 |
_aModulation of platinum-induced toxicities and therapeutic index: mechanistic insights and first- and second-generation protecting agents. _h[electronic resource] |
| 260 |
_bSeminars in oncology _cOct 1998 |
||
| 300 |
_a584-99 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAmifostine _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aCisplatin _xadverse effects |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Diseases _xchemically induced |
| 650 | 0 | 4 |
_aMesna _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPlatinum Compounds _xadverse effects |
| 650 | 0 | 4 |
_aProtective Agents _xpharmacology |
| 650 | 0 | 4 |
_aSulfhydryl Compounds _xchemistry |
| 700 | 1 | _aKanter, P | |
| 700 | 1 | _aCao, S | |
| 700 | 1 | _aHaridas, K | |
| 700 | 1 | _aSeetharamulu, P | |
| 700 | 1 | _aReddy, D | |
| 700 | 1 | _aPetluru, P | |
| 700 | 1 | _aZhao, M | |
| 700 | 1 | _aMurali, D | |
| 700 | 1 | _aSaxe, J D | |
| 700 | 1 | _aYao, S | |
| 700 | 1 | _aMartinez, N | |
| 700 | 1 | _aZukowski, A | |
| 700 | 1 | _aRustum, Y M | |
| 773 | 0 |
_tSeminars in oncology _gvol. 25 _gno. 5 _gp. 584-99 |
|
| 999 |
_c9748154 _d9748154 |
||